BioLine RX Ltd. ADR | Income Statement
Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
1,147.00
960.00
1,713.40
1,850.30
1,730.10
1,621.50
Gross Income
1,147.00
960.00
1,713.40
1,850.30
1,730.10
1,621.50
SG&A Expense
60,099.00
60,382.00
61,211.60
61,539.30
89,057.50
90,435.30
EBIT
61,246.00
61,342.00
62,925.00
63,389.50
90,787.60
92,056.70
Unusual Expense
5,032.00
11,977.00
5,614.10
794.60
784.10
6,266.50
Non Operating Income/Expense
7,824.00
2,939.00
353.60
3.80
478.40
2,351.30
Interest Expense
-
70.00
58.30
53.70
75.50
1,700.60
Pretax Income
61,438.00
39,620.00
55,947.20
60,809.90
87,593.50
82,554.40
Consolidated Net Income
61,438.00
39,620.00
55,947.20
60,809.90
87,593.50
82,554.40
Net Income
61,438.00
39,620.00
55,947.20
60,809.90
87,593.50
82,554.40
Net Income After Extraordinaries
61,438.00
39,620.00
55,947.20
60,809.90
87,593.50
82,554.40
Net Income Available to Common
61,438.00
39,620.00
55,947.20
60,809.90
87,593.50
82,554.40
EPS (Basic)
2.70
1.20
1.09
1.07
0.97
0.76
Basic Shares Outstanding
22,488.50
32,433.90
51,406.40
56,144.70
89,970.70
108,595.70
EPS (Diluted)
2.73
1.22
1.09
1.08
0.97
0.76
Diluted Shares Outstanding
22,488.50
32,433.90
51,406.40
56,144.70
89,970.70
108,595.70
EBITDA
60,099.00
60,382.00
61,211.60
61,539.30
89,057.50
90,435.30
Non-Operating Interest Income
2,600.00
12,754.00
1,775.50
1,842.60
2,963.90
2,585
About BioLine RX
View Profile
